Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
- Status
- TERMINATED
- Phase
- NA
Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Autologous Transplant for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Stem Cell Transplant for Hematological Malignancy
- Status
- TERMINATED
- Phase
- NA
Post Transplant Donor Lymphocyte Infusion
- Status
- TERMINATED
- Phase
- PHASE2
Protein Tyrosine Kinases (PTK) in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2